Computational science: New horizons and relevance to pharmaceutical design

Trends in Cardiovascular Medicine

Volumn 6, Issue 6, 1996, Pages 198-203

  Briggs, James M ^a   Marrone, Tami J ^a   McCammon, J Andrew ^a  

^a San Diego   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPUTER ANALYSIS; DRUG DESIGN; DRUG INDUSTRY; DRUG RESEARCH; INFORMATION PROCESSING; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW;

EID: 0030221199     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1050-1738(96)00068-0     Document Type: Review

References (54)

1. Ajay, Murko MA: 1995. Computational methods to predict binding free energy in ligand-receptor complexes. J Med Chem 38:4953-4967.
2. Antosiewicz J, Briggs JM, Ekock AH, Gilson MK, McCammon JA: 1996a. Computing the ionization states of proteins with a detailed charge model. J Comp Chem (in press).
3. Antosiewicz J, McCammon JA, Gilson MK: 1996b. The determinants of pKas in proteins. Biochemistry 35:7819-7833.
4. Åqvist J; Medina C, Samuelsson J-E: 1994. A new method for predicting binding affinity in computer-aided drug design. Protein Eng 7:385-391.
5. Belvisi L, Bravi G, Scolastico C, Vulpetti A, Salimbeni A, Todeshini R: 1994. A 3D QSAR approach to the search for geometrical similarity in a series of nonpeptide angiotensin II receptor antagonists. J Comput Aided Mol Des 8:211-220.
6. Böhm H-J: 1993. A novel computational tool for automated structure-based drug design. J Mol Recognit 6:131-137.
7. Bowen JP, Charifson PS, Fox PC, et al.: 1993. Computer-assisted molecular modeling: indispensable tools for molecular pharmacology. J Clin Pharmacol 33:1149-1164.
8. Caflisch A, Niederer P, Anliker M: 1992. Monte Carlo docking of oligonucleotides to proteins. Proteins 13:223-230.
9. Clare BW: 1995. The relationship of charge transfer complexes to frontier orbital energies in QSAR. J Mol Str 331:63-78.
10. Clark TW, Hanxleden RV, McCammon JA, Scott LR: 1994. Parallelization using spatial decomposition for molecular dynamics. In Proceedings of the Scaleable High Performance Computing Conference, Knoxville, TN. IEEE Computer Society, pp 95-102.
11. Damewood JR, Jr: 1996. Peptide mimetic design with the aid of computational chemistry. Rev Comp Chem 9:1-79.
12. Dhanaraj V, Dealwis CG, Frazao C, et al.: 1992. X-ray structure of peptide-inhibitor complexes define the structural basis for specificity for human and mouse renins. Nature 357: 466-472.
13. Dixon JS: 1992. Computer-aided drug design: getting the best results. Trends Biotech 10: 357-363.
14. Eisen MB, Wiley DC, Karplus M, Hubbard RE: 1994. HOOK; a program for finding novel molecular architectures that satisfy the chemical and steric requirements of a macromolecular binding site. Proteins 19:199-221.
15. Gehlhaar DK, Moerder KE, Zichi D, Sherman CJ, Ogden RC, Freer ST: 1995. De novo design of enzyme inhibitors by Monte Carlo ligand generation. J Med Chem 38:466-472.
16. Goodsell DS, Olson AJ : 1990. Automated docking of substrates to proteins by simulated annealing. Proteins 8:195-202.
17. Halgren TA: 1995. Potential Energy Functions. Curr Opinion Struct Bio 5:205-210.
18. Jackson RC: 1995. Update on computer-aided drug design. Curr Opinion Biotech 6:646-651.
19. Jain AN, Dietterich TG, Lathrop RH, et al.: 1994. Compass: a shape-based machine learning tool for drug design. J Comput Aided Mol Des 8:635-652.
20. Jones G, Willett P: 1995. Docking small-molecule ligands into active sites. Curr Opinion Biotech 6:652-656.
21. Jones G, Willett P, Geln RC: 1995. Molecular recognition of receptor sites using a genetic algorithm with a description of desolvation. J Mol Biol 245:43-53.
22. Judson RS, Jaeger EP, Treasurywala AM : 1994. A genetic algorithm based method for docking flexible molecules. J Mol Struct-Theochem 308:191-206.
23. Kaminski JJ: 1994. Computer-assisted drug design and selection. Adv Drug Delivery Rev 14:331-337.
24. Kiyama R, Honma T, Hayashi K, et al.: 1995. Novel angiotensin II receptor antagonists: design, synthesis, and in vitro evaluation of dibenzo[a,d]cycloheptene and dibenzo[b,f] oxepin derivatives: searching for bioisosteres of biphenyltetrazole using a three-dimensional search technique. J Med Chem 38:2728-2741.
25. Klebe G, Abraham U, Mietzner T: 1994. Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity. J Med Chem 37:4130-4146.
26. Kuntz ID, Blaney JM, Oatley SJ , et al.: 1982. A geometric approach to macromolecule-ligand interactions. J Mol Biol 161:269-288.
27. Kuntz ID, Meng EC, Shoichet BK: 1994. Structure-based molecular design. Acc Chem Res 27:117-123.
28. Lauri G, Bartlett PA: 1994. CAVEAT: a program to facilitate the design of organic molecules. J Comput Aided Mol Des 8:51-66.
29. Leach AR: 1994. Ligand docking to proteins with discrete side-chain flexibility. J Mol Biol 243:310-326.
30. Loew GH, Villar HO, Alkorta I: 1993. Strategies for indirect computer-aided drug design. Pharm Res 10:475-486.
31. Luty BA, Wasserman ZR, Stouten PFW, et al: 1995. A molecular mechanics/grid method for evaluation of ligand-receptor interactions. J Comput Chem 16:454-464.
32. Lybrand TP: 1995. Ligand-protein docking and rational drug design. Curr Opinion Struct Bio 5:224-228.
33. Madura JD, Briggs JM, Wade RC, et al.: 1995. Electrostatics and diffusion of molecules in solution: simulations with the University of Houston Brownian Dynamics program. Comp Phys Commun 91:57-95.
34. Marrone TJ, Briggs JM, McCammon JA: 1997. Computer-assisted drug design. Ann Rev Pharmacol Toxicol 37 (in press).
35. Martin YC: 1991. Computer-assisted rational drug design. Methods Enzymol 203:587-613.
36. Martin YC: 1992. 3D database searching in drug design. J Med Chem 35:2145-2154.
37. Martin YC, Bures MG, Danaher EA, DeLazzer J, Lico I, Pavlik PA: 1993. A fast new approach to pharmacophore mapping and its application to dopaminergic and benzodiazepine agonists. J Comput Aided Mol Des 7:83-102.
38. Naray-Szabo G, Balogh T: 1993. The average molecular electrostatic field as a QSAR descriptor. Part 4. Hydrophobicity scales for amino acid residues. J Mol Str 284:243-248.
39. Ortiz AR, Pisabarro MT, Gago F, Wade RC: 1995. Prediction of drug binding affinities by comparative binding energy analysis. J Med Chem 38:2681-2691.
40. Oshiro CM, Kuntz ID, Dixon JS: 1995. Flexible ligand docking using a genetic algorithm. J Comput Aided Mol Des 9:113-130.
41. Plummer MS, Shahripour A, Kaltenbronn JS, et al.: 1995. Design and synthesis of renin inhibitors: incorporation of transition-state isostere side chains that span from the S1 to the S3 binding pockets and examination of the P3-modified renin inhibitors. J Med Chem 38:2893-2905.
42. Reich SH, Webber SE: 1993. Structure-based drug design (SBDD): every structure tells a story. Perspec Drug Discov Design 371-390.
43. 1 selective angiotensin II receptor antagonists. J Med Chem 38:4806-4820.
44. Smith III AB, Akaishi R, Jones DR: 1995. Design and synthesis of nonpeptide peptidomimetic inhibitors of renin. Biopolymers 37:29-53.
45. Strynadka NCJ, Eisenstein M, Katchalski-Katzir E, et al.: 1996. Molecular docking programs successfully predict the binding of a (β-lactamase inhibitory protein to TEM-1 β-lactamase. Nat Struct Biol3:233-239.
46. Sun E, Cohen FE: 1993. Computer-aided drug discovery: a review. Gene 137:127-132.
47. Tong W, Collantes ER, Chen Y, at al: 1996. A comparative molecular field analysis study of N-benzylpiperidines as acetylcholinesterase inhibitors. J Med Chem 39:380-387.
48. Veerapandian B: 1995. Three dimensional structure-aided drug design. In Wolff ME, ed. Burger's Medicinal Chemistry and Drug Discovery, 5th ed. New York, John Wiley & Sons, pp 303-348.
49. Warshel A, Tao H, Fothergill M, Chu Z-T: 1994. Effective methods for estimation of binding energies in computer-aided drug design. Isr J Chem 34:253-256.
50. Waszkowycz B, Clark DE, Frenkel D, et al.: 1994. PRO_LIGAND: an approach to de novo molecular design. 2. Design of novel molecules from molecular field analysis (MFA) models and pharmacophores. J Med Chem 37:3994-4002.
51. Wexler RR, Greenlee WJ, Irvin JD, et al.: 1996. Nonpeptide angiotensin II receptor antagonists: the next generation in antihypertensive therapy. J Med Chem 39:625-656.
52. Whittle PJ, Blundell TL: 1994. Protein structure-based drug design. Annu Rev Biophys Biomol Struct 23:349-375.
53. Wlodek ST, Antosiewicz J, McCammon JA, et al.: 1996. Binding of tacrine and 6-chlorotacrine by acetylcholinesterase. Biopolymers 38:109-117.
54. Yanagisawa H, Amemiya Y, Kanazaki T, et al.: 1996. Nonpeptide angiotensin II receptor antagonists: synthesis, biological activities, and structure-activity relationships on imidazole-5-carboxylic acids bearing alkyl, alkenyl, and hydroxyalkyl substituents at the 4-position and their related compounds. J Med Chem 39:323-338.